McKesson (MCK) Tops Q2 EPS Views; Approves New $2B Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
McKesson Reports Fiscal 2016 Second-Quarter Results
October 29, 2015 7:30 AM EDTRevenues of $48.8 billion for the second quarter, up 10%. Second-quarter GAAP earnings per diluted share from continuing operations of $2.65, up 29%. Second-quarter Adjusted Earnings per diluted share of $3.31, up 19%. Consolidated results include a pre-tax gain of $51 million, or 14 cents per diluted share, from the sale of our ZEE Medical business. Board of Directors authorized a new $2 billion share repurchase program. Fiscal 2016 Outlook: Adjusted Earnings per diluted share of $12.50 to $13.00.
SAN... More
